SAMM50
geneOn this page
Also known as CGI-51TRG-3YNL026WOMP85TOB55SAM50
Summary
SAMM50 (SAMM50 sorting and assembly machinery component, HGNC:24276) is a protein-coding gene on chromosome 22q13.31, encoding Sorting and assembly machinery component 50 homolog (Q9Y512). Plays a crucial role in the maintenance of the structure of mitochondrial cristae and the proper assembly of the mitochondrial respiratory chain complexes. It is a selective cancer dependency (DepMap: 58.3% of cell lines).
This gene encodes a component of the Sorting and Assembly Machinery (SAM) of the mitochondrial outer membrane. The Sam complex functions in the assembly of beta-barrel proteins into the outer mitochondrial membrane.
Source: NCBI Gene 25813 — RefSeq curated summary.
At a glance
- GWAS associations: 18
- Clinical variants (ClinVar): 107 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 58.3% of screened cell lines
- MANE Select transcript:
NM_015380
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24276 |
| Approved symbol | SAMM50 |
| Name | SAMM50 sorting and assembly machinery component |
| Location | 22q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-51, TRG-3, YNL026W, OMP85, TOB55, SAM50 |
| Ensembl gene | ENSG00000100347 |
| Ensembl biotype | protein_coding |
| OMIM | 612058 |
| Entrez | 25813 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 10 protein_coding, 3 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000350028, ENST00000465768, ENST00000474323, ENST00000493161, ENST00000493621, ENST00000494795, ENST00000854676, ENST00000854677, ENST00000937405, ENST00000937406, ENST00000937407, ENST00000943220, ENST00000943221, ENST00000943222, ENST00000943223
RefSeq mRNA: 1 — MANE Select: NM_015380
NM_015380
CCDS: CCDS14055
Canonical transcript exons
ENST00000350028 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000656936 | 43976055 | 43976183 |
| ENSE00001390462 | 43955442 | 43955598 |
| ENSE00001920991 | 43996338 | 43996529 |
| ENSE00003476200 | 43981391 | 43981461 |
| ENSE00003478097 | 43963286 | 43963396 |
| ENSE00003493134 | 43989111 | 43989257 |
| ENSE00003497020 | 43972236 | 43972342 |
| ENSE00003508600 | 43968731 | 43968818 |
| ENSE00003540282 | 43972871 | 43973001 |
| ENSE00003553809 | 43964452 | 43964553 |
| ENSE00003580187 | 43977872 | 43977958 |
| ENSE00003582608 | 43976750 | 43976821 |
| ENSE00003608710 | 43973236 | 43973323 |
| ENSE00003639717 | 43990265 | 43990406 |
| ENSE00003679796 | 43983933 | 43984000 |
Expression profiles
Bgee: expression breadth ubiquitous, 292 present calls, max score 97.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 40.3200 / max 230.9802, expressed in 1819 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 192626 | 31.1588 | 1816 |
| 192624 | 5.0446 | 1701 |
| 192627 | 3.8697 | 1539 |
| 192625 | 0.2470 | 75 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 97.67 | gold quality |
| vastus lateralis | UBERON:0001379 | 97.67 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 97.50 | gold quality |
| quadriceps femoris | UBERON:0001377 | 97.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.32 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.31 | gold quality |
| muscle of leg | UBERON:0001383 | 97.18 | gold quality |
| muscle organ | UBERON:0001630 | 97.16 | gold quality |
| diaphragm | UBERON:0001103 | 96.99 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 96.76 | gold quality |
| triceps brachii | UBERON:0001509 | 96.60 | gold quality |
| body of tongue | UBERON:0011876 | 96.32 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 96.22 | gold quality |
| muscle tissue | UBERON:0002385 | 96.09 | gold quality |
| biceps brachii | UBERON:0001507 | 95.94 | gold quality |
| deltoid | UBERON:0001476 | 95.91 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 95.84 | gold quality |
| gluteal muscle | UBERON:0002000 | 95.77 | gold quality |
| apex of heart | UBERON:0002098 | 95.73 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.67 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.58 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.54 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.51 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 95.47 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.25 | gold quality |
| right uterine tube | UBERON:0001302 | 95.12 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.11 | gold quality |
| nephron tubule | UBERON:0001231 | 95.08 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.96 | gold quality |
| parotid gland | UBERON:0001831 | 94.91 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting SAMM50, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-4711-3P | 98.97 | 66.87 | 1020 |
| HSA-MIR-644A | 96.02 | 66.52 | 786 |
| HSA-MIR-1238-3P | 95.27 | 62.25 | 552 |
| HSA-MIR-9899 | 91.24 | 59.59 | 90 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 58.3% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 15)
- The pathway of Voltage-dependent anion-selective channel biogenesis in human mitochondria involves the TOM complex, Sam50 and metaxins, and that it is evolutionarily conserved. (PMID:17510655)
- mitofilin helps regulate mitochondrial morphology and at least four of the associated proteins (metaxins 1 and 2, SAM50 and CHCHD3) have been implicated in protein import (PMID:17624330)
- The study describes a novel role of SAM50 in maintaining the mitochondrial shape and the morphology of cristae. (PMID:22252321)
- Polymorphisms in the SAMM50 and PARVB genes in addition to those in the PNPLA3 gene were observed to be associated with the development and progression of NAFLD. (PMID:23535911)
- the integrity of MICOS and its efficient interaction with Sam50 are indispensable for cristae organization, which is relevant to mitochondrial function. (PMID:26530328)
- downregulation of SAM50 in BCR-ABL-expressing, but not normal CD34(+) human hematopoietic stem and progenitor cells (HSPCs) caused a significant decrease in growth, colony formation, and replating capacity. (PMID:26855047)
- SAMM50 affects the Drp1-dependent mitochondrial morphology. (PMID:27059175)
- Sub-mitochondrial localization of the genetic-tagged mitochondrial intermembrane space-bridging components Mic19, Mic60 and Sam50. (PMID:28808085)
- The authors results demonstrate that SNP in the SAMM50 gene is significantly associated with the presence and severity of NAFLD in a Korean populations. (PMID:29271184)
- Findings suggest a significant association between variants in COL13A1, ADIPOQ, SAMM50, and PNPLA3, and risk of NAFLD/elevated transaminase levels in Mexican adults with an admixed ancestry. (PMID:29307798)
- Sam50, the core component of the sorting and assembly machinery (SAM), is a critical regulator of mitochondrial dynamics and PINK1-Parkin-mediated mitophagy. (PMID:29874585)
- The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms. (PMID:33728819)
- SAMM50 acts with p62 in piecemeal basal- and OXPHOS-induced mitophagy of SAM and MICOS components. (PMID:34037656)
- Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children. (PMID:34490745)
- Loss of Sam50 in hepatocytes induces cardiolipin-dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury. (PMID:35313046)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | samm50l | ENSDARG00000039681 |
| danio_rerio | samm50 | ENSDARG00000045814 |
| mus_musculus | Samm50 | ENSMUSG00000022437 |
| rattus_norvegicus | Samm50 | ENSRNOG00000011952 |
| drosophila_melanogaster | CG7639 | FBGN0033989 |
| caenorhabditis_elegans | WBGENE00001662 |
Protein
Protein identifiers
Sorting and assembly machinery component 50 homolog — Q9Y512 (reviewed: Q9Y512)
Alternative names: Transformation-related gene 3 protein
All UniProt accessions (1): Q9Y512
UniProt curated annotations — full annotation on UniProt →
Function. Plays a crucial role in the maintenance of the structure of mitochondrial cristae and the proper assembly of the mitochondrial respiratory chain complexes. Required for the assembly of TOMM40 into the TOM complex.
Subunit / interactions. Associates with the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and QIL1/MIC13. This complex was also known under the names MINOS or MitOS complex. The MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1 and MTX2 (together described as components of the mitochondrial outer membrane sorting assembly machinery (SAM) complex) and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9. The MICOS and SAM complexes together with DNAJC11 are part of a large protein complex spanning both membranes termed the mitochondrial intermembrane space bridging (MIB) complex. Interacts with CHCHD3/MIC19. Interacts with ARMC1. (Microbial infection) Interacts with parasite T.gondii RH strain MAF1b1; the interaction is probably indirect and results in the disruption of the MIB complex and the formation of SPOTs (structures positive for outer mitochondrial membrane (OMM)), a cellular response to OMM stress, which leads to the constitutive shedding of OMM vesicles.
Subcellular location. Mitochondrion outer membrane. Cytoplasm. Mitochondrion.
Domain organisation. Its C-terminal part seems to contain many membrane-spanning sided beta-sheets, that have the potential to adopt a transmembrane beta-barrel type structure.
Similarity. Belongs to the SAM50/omp85 family.
RefSeq proteins (1): NP_056195* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000184 | Bac_surfAg_D15 | Domain |
| IPR034746 | POTRA | Domain |
| IPR039910 | D15-like | Family |
Pfam: PF01103
UniProt features (9 total): sequence conflict 3, sequence variant 2, chain 1, domain 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6YOO | X-RAY DIFFRACTION | 1.06 |
| 6YOP | X-RAY DIFFRACTION | 1.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y512-F1 | 86.23 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 255
Function
Pathways and Gene Ontology
Reactome pathways
10 pathways
| ID | Pathway |
|---|---|
| R-HSA-1268020 | Mitochondrial protein import |
| R-HSA-8949613 | Cristae formation |
| R-HSA-9013404 | RAC2 GTPase cycle |
| R-HSA-1592230 | Mitochondrial biogenesis |
| R-HSA-162582 | Signal Transduction |
| R-HSA-1852241 | Organelle biogenesis and maintenance |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-9012999 | RHO GTPase cycle |
| R-HSA-9609507 | Protein localization |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
MSigDB gene sets: 172 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_CRISTAE_FORMATION, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOCC_MITOCHONDRIAL_ENVELOPE, GARY_CD5_TARGETS_DN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, MAF_Q6, TIEN_INTESTINE_PROBIOTICS_24HR_UP, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT
GO Biological Process (4): inner mitochondrial membrane organization (GO:0007007), protein import into mitochondrial matrix (GO:0030150), cristae formation (GO:0042407), protein insertion into mitochondrial outer membrane (GO:0045040)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): SAM complex (GO:0001401), mitochondrion (GO:0005739), mitochondrial outer membrane (GO:0005741), membrane (GO:0016020), extracellular exosome (GO:0070062), MIB complex (GO:0140275), cytoplasm (GO:0005737), outer membrane (GO:0019867)
Reactome top-level categories
Rollup of top-7 pathways:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
| Mitochondrial biogenesis | 1 |
| RHO GTPase cycle | 1 |
| Organelle biogenesis and maintenance | 1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 |
| Signaling by Rho GTPases | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| mitochondrial membrane organization | 1 |
| protein transmembrane import into intracellular organelle | 1 |
| protein localization to mitochondrion | 1 |
| import into the mitochondrion | 1 |
| mitochondrial protein import pathway | 1 |
| inner mitochondrial membrane organization | 1 |
| outer mitochondrial membrane organization | 1 |
| protein insertion into mitochondrial membrane | 1 |
| binding | 1 |
| mitochondrial outer membrane translocase complex | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| extracellular vesicle | 1 |
| inner mitochondrial membrane protein complex | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
Protein interactions and networks
STRING
2538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SAMM50 | TOMM40 | O96008 | 986 |
| SAMM50 | CHCHD3 | Q9NX63 | 986 |
| SAMM50 | MTX2 | O75431 | 983 |
| SAMM50 | TOMM22 | Q9NS69 | 968 |
| SAMM50 | IMMT | Q16891 | 967 |
| SAMM50 | MTX1 | Q13505 | 918 |
| SAMM50 | PNPLA3 | Q9NST1 | 911 |
| SAMM50 | TOMM20 | Q15388 | 911 |
| SAMM50 | DNAJC11 | Q9NVH1 | 871 |
| SAMM50 | MTX3 | Q5HYI7 | 864 |
| SAMM50 | TOMM70 | O94826 | 857 |
| SAMM50 | CHCHD6 | Q9BRQ6 | 822 |
| SAMM50 | TIMM23 | O14925 | 782 |
| SAMM50 | APOO | Q9BUR5 | 779 |
| SAMM50 | MICOS10 | Q5TGZ0 | 766 |
IntAct
144 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMARCB1 | ARID1A | psi-mi:“MI:0914”(association) | 0.860 |
| EXOC6 | EXOC5 | psi-mi:“MI:0914”(association) | 0.840 |
| SAMM50 | CHCHD3 | psi-mi:“MI:0915”(physical association) | 0.780 |
| CHCHD3 | SAMM50 | psi-mi:“MI:0915”(physical association) | 0.780 |
| IMMT | MTX2 | psi-mi:“MI:0914”(association) | 0.730 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| RETREG3 | PLSCR1 | psi-mi:“MI:0914”(association) | 0.640 |
| DNM1L | SAMM50 | psi-mi:“MI:0915”(physical association) | 0.600 |
| SAMM50 | DNM1L | psi-mi:“MI:0915”(physical association) | 0.600 |
| SAMM50 | DNM1L | psi-mi:“MI:0407”(direct interaction) | 0.600 |
| CHCHD6 | SAMM50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMMDC1 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.530 |
| APOOL | MTX2 | psi-mi:“MI:0914”(association) | 0.530 |
| CLEC5A | TSPAN6 | psi-mi:“MI:0914”(association) | 0.530 |
| TRAK2 | OGT | psi-mi:“MI:0914”(association) | 0.530 |
| TRAK1 | MTX2 | psi-mi:“MI:0914”(association) | 0.530 |
| CD244 | MTX2 | psi-mi:“MI:0914”(association) | 0.530 |
| RAB8A | EXOC5 | psi-mi:“MI:0914”(association) | 0.510 |
| ORF10 | SAMM50 | psi-mi:“MI:0915”(physical association) | 0.480 |
| AIFM1 | HAX1 | psi-mi:“MI:0914”(association) | 0.420 |
| HTRA2 | HAX1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| SAMM50 | MFN2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Erh | BCLAF3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MTX1 | MTX2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (295): CHCHD3 (Two-hybrid), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Two-hybrid), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), SAMM50 (Affinity Capture-MS), RAB8A (Affinity Capture-MS)
ESM2 similar proteins: A2VE14, A5PLN9, A7MB28, B1WC68, O54865, O70133, O70496, P16068, P20595, P51798, P51799, Q02153, Q0VCB2, Q2HJ55, Q3TIR1, Q4PKH3, Q4R4U1, Q4R5H6, Q4ZHR9, Q5M887, Q5NVN7, Q5R5F8, Q5RCG0, Q5RES2, Q5RKN4, Q5U3I0, Q5VU57, Q5XIC4, Q6AXQ0, Q6AXV4, Q6AYR2, Q6P1X5, Q6P806, Q6PA35, Q7ZWS5, Q803G5, Q8BGH2, Q8BTG7, Q8MJJ1, Q8VH37
Diamond homologs: P46576, Q2HJ55, Q5U3I0, Q6AXV4, Q6P806, Q6PA35, Q7ZWS5, Q803G5, Q8BGH2, Q9Y512, P53969, Q10478, Q9V784
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SAMM50 | “form complex” | “SAM complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 167 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Cristae formation | 8 | 27.1× | 2e-07 |
| Transport of vitamins, nucleosides, and related molecules | 6 | 16.0× | 3e-04 |
| Mitochondrial biogenesis | 9 | 14.8× | 2e-06 |
| Organelle biogenesis and maintenance | 9 | 5.8× | 2e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cristae formation | 7 | 52.3× | 1e-08 |
| inner mitochondrial membrane organization | 8 | 47.8× | 2e-09 |
| mitochondrion organization | 8 | 8.6× | 9e-04 |
| transmembrane transport | 7 | 8.4× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
107 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 71 |
| Likely benign | 5 |
| Benign | 7 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2360 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:43955595:CCGGG:C | donor_loss | 1.0000 |
| 22:43955596:CGGGT:C | donor_loss | 1.0000 |
| 22:43955597:GGGTA:G | donor_loss | 1.0000 |
| 22:43963285:GA:G | acceptor_gain | 1.0000 |
| 22:43963376:G:GT | donor_gain | 1.0000 |
| 22:43963377:A:T | donor_gain | 1.0000 |
| 22:43963392:AAGAT:A | donor_gain | 1.0000 |
| 22:43963393:AGAT:A | donor_gain | 1.0000 |
| 22:43963394:GAT:G | donor_gain | 1.0000 |
| 22:43963394:GATG:G | donor_gain | 1.0000 |
| 22:43963395:AT:A | donor_gain | 1.0000 |
| 22:43963395:ATG:A | donor_loss | 1.0000 |
| 22:43963396:TG:T | donor_loss | 1.0000 |
| 22:43963397:G:GG | donor_gain | 1.0000 |
| 22:43964447:TTTA:T | acceptor_loss | 1.0000 |
| 22:43964448:TTA:T | acceptor_loss | 1.0000 |
| 22:43964449:TAGGT:T | acceptor_loss | 1.0000 |
| 22:43964450:A:AG | acceptor_gain | 1.0000 |
| 22:43964450:A:T | acceptor_loss | 1.0000 |
| 22:43964450:AG:A | acceptor_gain | 1.0000 |
| 22:43964450:AGGT:A | acceptor_gain | 1.0000 |
| 22:43964450:AGGTG:A | acceptor_gain | 1.0000 |
| 22:43964451:G:GC | acceptor_loss | 1.0000 |
| 22:43964451:G:GG | acceptor_gain | 1.0000 |
| 22:43964451:GG:G | acceptor_gain | 1.0000 |
| 22:43964451:GGT:G | acceptor_gain | 1.0000 |
| 22:43964451:GGTG:G | acceptor_gain | 1.0000 |
| 22:43964451:GGTGG:G | acceptor_gain | 1.0000 |
| 22:43964553:GGTA:G | donor_loss | 1.0000 |
| 22:43972231:TTTA:T | acceptor_loss | 1.0000 |
AlphaMissense
3057 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:43964459:T:A | V47D | 1.000 |
| 22:43964468:T:A | V50D | 0.999 |
| 22:43972266:T:A | V118D | 0.999 |
| 22:43972272:T:C | F120S | 0.999 |
| 22:43976104:G:C | R233P | 0.999 |
| 22:43990327:G:T | G429W | 0.999 |
| 22:43990355:C:A | A438D | 0.999 |
| 22:43996375:T:C | F468L | 0.999 |
| 22:43996377:C:A | F468L | 0.999 |
| 22:43996377:C:G | F468L | 0.999 |
| 22:43968783:T:C | F96S | 0.998 |
| 22:43972894:T:A | N151K | 0.998 |
| 22:43972894:T:G | N151K | 0.998 |
| 22:43983965:G:A | G347E | 0.998 |
| 22:43983967:T:C | F348L | 0.998 |
| 22:43983969:C:A | F348L | 0.998 |
| 22:43983969:C:G | F348L | 0.998 |
| 22:43990321:G:T | G427W | 0.998 |
| 22:43990322:G:A | G427E | 0.998 |
| 22:43990328:G:A | G429E | 0.998 |
| 22:43990371:T:A | N443K | 0.998 |
| 22:43990371:T:G | N443K | 0.998 |
| 22:43996366:G:T | G465W | 0.998 |
| 22:43968743:T:C | S83P | 0.997 |
| 22:43968752:G:C | A86P | 0.997 |
| 22:43968756:G:C | R87P | 0.997 |
| 22:43968765:T:C | L90S | 0.997 |
| 22:43968782:T:C | F96L | 0.997 |
| 22:43968784:T:A | F96L | 0.997 |
| 22:43968784:T:G | F96L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000020388 (22:43991274 C>G), RS1000045511 (22:43977231 T>G), RS1000050112 (22:43991081 A>G), RS1000151542 (22:43959542 A>T), RS1000157701 (22:43976390 T>C), RS1000269235 (22:43982295 C>A,T), RS1000359202 (22:43963806 G>A), RS1000420820 (22:43969663 C>A,G), RS1000425612 (22:43987438 G>T), RS1000487724 (22:43996767 G>A), RS1000492778 (22:43977745 C>A,G,T), RS1000512317 (22:43986586 T>C), RS1000703203 (22:43974952 A>C), RS1000731994 (22:43989417 A>C), RS1000745442 (22:43981879 A>T)
Disease associations
OMIM: gene MIM:612058 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
18 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000248_9 | Liver enzyme levels | 8.000000e-16 |
| GCST000583_15 | Hematological and biochemical traits | 2.000000e-12 |
| GCST000583_18 | Hematological and biochemical traits | 2.000000e-12 |
| GCST001275_2 | Liver enzyme levels (alanine transaminase) | 1.000000e-45 |
| GCST001576_3 | Nonalcoholic fatty liver disease | 6.000000e-07 |
| GCST001928_4 | Pediatric non-alcoholic fatty liver disease activity score | 2.000000e-20 |
| GCST003302_6 | Cholesterol, total | 3.000000e-08 |
| GCST004235_56 | Total cholesterol levels | 1.000000e-06 |
| GCST005190_2 | Nonalcoholic fatty liver disease | 2.000000e-11 |
| GCST005308_4 | Nonalcoholic fatty liver disease | 1.000000e-18 |
| GCST005309_3 | Nonalcoholic steatohepatitis-derived hepatocellular carcinoma | 9.000000e-07 |
| GCST006867_89 | Type 2 diabetes | 3.000000e-10 |
| GCST007440_5 | Alanine aminotransferase levels | 7.000000e-06 |
| GCST009391_324 | Metabolite levels | 7.000000e-06 |
| GCST009391_330 | Metabolite levels | 9.000000e-06 |
| GCST009391_339 | Metabolite levels | 3.000000e-06 |
| GCST010396_46 | Gut microbiota (bacterial taxa, hurdle binary method) | 7.000000e-06 |
| GCST90091033_8 | Nonalcoholic fatty liver disease | 7.000000e-12 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004736 | aspartate aminotransferase measurement |
| EFO:0004574 | total cholesterol measurement |
| EFO:0010431 | triacylglycerol 56:4 measurement |
| EFO:0010432 | triacylglycerol 56:5 measurement |
| EFO:0010433 | triacylglycerol 56:6 measurement |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066285 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.09 | Kd | 8.063 | nM | CHEMBL5653589 |
| 8.09 | ED50 | 8.063 | nM | CHEMBL5653589 |
| 6.11 | Kd | 783.8 | nM | CHEMBL3752910 |
| 6.11 | ED50 | 783.8 | nM | CHEMBL3752910 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149339: Binding affinity to human SAMM50 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0081 | uM |
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149339: Binding affinity to human SAMM50 incubated for 45 mins by Kinobead based pull down assay | kd | 0.7838 | uM |
CTD chemical–gene interactions
42 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, decreases methylation, affects cotreatment, increases expression | 3 |
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| Cisplatin | affects expression, increases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol A | increases expression | 1 |
| sodium arsenate | decreases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2,3,5-(triglutathion-S-yl)hydroquinone | increases ADP-ribosylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| abrine | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic | increases abundance, increases expression, affects cotreatment | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lead | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652381 | Binding | Binding affinity to human SAMM50 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cirrhosis of liver, hepatocellular carcinoma, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease